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Cardiac“Friends come and go but enemies accumulate.” — Arthur Bloch
Mitochondrial networks in eukaryotic cells are maintained via regular cycles of degradation and biogenesis.
These complex processes function in concert with one another to eliminate dysfunctional mitochondria in a spe-
ciﬁc and targetedmanner and coordinate the biogenesis of new organelles. This review covers the two aspects of
mitochondrial turnover, focusing on themain pathways and mechanisms involved. The review also summarizes
the current methods and techniques for analyzing mitochondrial turnover in vivo and in vitro, from the whole
animal proteome level to the level of single organelle. This article is part of a Special Issue entitled: Mitophagy.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The endosymbiotic event that occurred billions of years ago between
the SAR11 clade Rickettsiales and the microorganism which accepted
them up sparked the evolution of all eukaryotic life on the planet [1].
These bacteria, which over time transformed into organelles we now
callmitochondria, play a crucial role inmaintaining all cellular functions
as the most efﬁcient and abundant source of adenosine triphosphate
(ATP), essential for meeting the energetic demands of eukaryotic cells.
For example, in the heart, mitochondria are by far the most abundant
organelle and the main source (~90%) of ATP (via oxidative phosphory-
lation) required for contraction of the organ [2]. Furthermore, mito-
chondria regulate calcium stores [3], fuel utilization [4], intracellular
signaling [5] and apoptosis [6]. Due to this wide spectrum of cellular
functions that mitochondria are involved in, the organelles play a pivot-
al role in mediating cellular homeostasis. As a result, maintenance of a
healthy population of mitochondria is essential for cell survival. This is
especially important due to the fact that mitochondria in a cell produce
ATP at differential rates, comprising a heterogeneous population [7].
Those organelles which are quiescent, inefﬁcient at ATP production or
producing high levels of reactive oxygen species (ROS) combine to con-
tribute to an extremely heterogeneous network. Impairedmitochondri-
al quality control results in accumulation of damagedmitochondria that
may releasemore reactive oxygen species [8], produce less ATP [9], have
a lower threshold for cytochrome c release resulting in apoptosis [10],
undergo mitochondrial permeability transition pore (MPTP) openinggy.
tute, 127 S. San Vicente Blvd.
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. This is an open access article underresulting in necrosis [11], or may release mitochondrial components
(mtHSP60, oxidizedmitochondrial DNA) into cytosol where its recogni-
tion by receptors for damage-associated molecular patterns (DAMP)
activates inﬂammation [12]. Mitochondrial turnover is therefore an in-
tegral aspect of quality control in which dysfunctional mitochondria
are selectively eliminated through autophagy (mitophagy) and re-
placed through expansion of preexisting mitochondria (biogenesis)
[13]. In this review, we focus on the mechanics of mitochondrial turn-
over and the techniques currently employed to measure and monitor
the dynamic network, constantly kept in balance by two arms of mito-
chondrial quality control: mitophagy and mitochondrial biogenesis.
1.1. Mitophagy
In order to maintain an efﬁcient supply of energy to the cell, mito-
chondria must constantly perform maintenance on a molecular and
network level. On a protein level, this is absolutely crucial due to the
fact that oxidative phosphorylation (OX-PHOS) leads to oxidative dam-
age to mitochondrial proteins over time [14]. Furthermore, the vast
majority of mitochondrial proteins are encoded in the nucleus, and ac-
cumulation of respiratory chain subunits can lead to an imbalance in re-
spiratory chain complexes. To address this problem, mitochondria
contain a number of proteases responsible for targeted protein quality
control (UPRmt, the mitochondrial unfolded protein response): most
prominently by the Lon protease and other AAA+ family proteases
(ATPases associated with a variety of cellular activities) [15]. These pro-
teases degrade the superﬂuous subunits into small peptides and act like
chaperones to extract unfolded proteins from the inner mitochondrial
membrane and target them for degradation via the proteasome [16].
Although the mechanism of removal of these peptides from the mito-
chondria into the cytosol is unclear, in mammals the responsiblethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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elegans protein Haf1 which removes peptide fragments generated by
the C. elegans protease ClpP [17]. The extruded peptides are recognized
by transcription factors CHOP, C/EBPβ, and cJun/AP1, which upregulate
the expression of UPRmt factors such as mitochondrial chaperone
hsp60, ClpP, Yme1L1, and MPPβ, Tim17A, NDUFB2, and EndoG. [18].
Finally, in response to the unfolded mitochondrial proteins, PKR
(double-stranded RNA-activated protein kinase) phosphorylates eIF2α
and cJun, thereby suppressing the translation and import of nuclear-
encoded mitochondrial proteins [19].
However, this targeted approach is not sufﬁcient for rapid removal
of whole dysfunctional mitochondria or a large number of damaged
components. To accomplish this, cells employ the process of selective
mitochondrial autophagy (mitophagy), which eliminates damaged
and dysfunctional mitochondria permitting the synthesis of new mito-
chondrial components and their insertion into the remaining functional
mitochondria. Using the heart as an example again, mitochondria turn
over with a half-life of 14 days [20]. Rat cardiomyocytes have roughly
1000 mitochondria per cell, suggesting that under basal resting con-
ditions, one mitochondrion per cell is replaced every 40min. Intrigu-
ingly, a number of enzymes involved in oxidative phosphorylation
(OX-PHOS) are expressed with diurnal variation, suggesting that mito-
chondrial turnover is regulated by the circadian cycle. This seems likely
given that a period of fasting occurs during sleep; therefore mitochon-
drial elimination may alternate with regeneration on a daily basis in a
manner resembling a sinewave, with % of themitochondrial population
replaced each day. However, this may be much higher: in the cultured
mouse atrial cell line HL-1 subjected to nutrient deprivation, the num-
ber of mitochondria is reduced by 70% within 3.5 h [21].
Eukaryotic cells generally rely on two processes to eliminate and
recycle components to maintain homeostasis working in concert: the
ubiquitin proteasome system (UPS) and autophagy. Autophagy is a
cellular degradation system in eukaryotic cells that allows for the bulk
recycling of unwanted cytoplasmic aggregate proteins or dysfunctional
organelles in a lysosome-dependent manner [22]. In order to facilitate
and initiate mitophagy, mitochondrial dynamics (fusion and ﬁssion)
play a critical role in mitochondrial turnover, favoring ﬁssion and sup-
pressing fusion, enabling engulfment by autophagosomes. Fission of
reticulate mitochondria into smaller fragments is a crucial requirement
for mitophagy to occur [23,24]. The key regulator of this process is
dynamin-related protein 1 (Drp1), a GTPase in the dynamin super family
of proteins recruited to themitochondria, which in concert with proteins
ﬁssion 1 (Fis1), mitochondrial ﬁssion factor (Mff), and mitochondrial
dynamics proteins of 49 (MiD49) and 51 kDa (MiD51) is responsible
for mitochondrial fragmentation [25–28]. While the importance of Fis1
as a ﬁssion partner of Drp1 is unclear and may be cell-type dependent,
the role of the other three proteins appears essential: Mff assists in the
assembly of Drp1 and MiD49 and MiD51 may play a regulatory role by
recruiting Drp1 and maintaining it in inactive state until ﬁssion is
required, stimulated by cell signaling [29]. Proteins that promote OMM
fusion such asMitofusin 1 and 2 (Mfn1 and 2) are ubiquitinated and elim-
inated by the UPS, while other proteins such as Optic atrophy protein 1
(OPA, regulator of fusion of the inner mitochondrial membrane), are de-
graded during mitophagy by the inner membrane zinc metalloprotease
OMA1 and AAA proteases [30–32].
The best-characterized pathway of mitophagy depends on the
recruitment of E3 ubiquitin ligase Parkin. Mitophagy in this context is
triggered by cellular stresses such as ischemia,which trigger depolariza-
tion of the outer mitochondrial membrane (OMM) (best induced by
utilizing chemical uncouplers of mitochondria such as carbonyl cyanide
4-(triﬂuoromethoxy) phenylhydrazone (FCCP) or carbonyl cyanide
m-chlorophenylhydrazone (CCCP)) [33]. The depolarization results in
stabilization of the serine/threonine kinase phosphatase and tensin
homolog (PTEN)-induced kinase 1 (PINK1) on the outer mitochondrial
membrane (OMM) and recruitment of the E3 ubiquitin ligase Parkin,
which attaches ubiquitin moieties to OMM proteins [34–37]. Theinterplay between PINK1 and Parkin is a crucial step in mediating the
clearance of dysfunctional mitochondria [38,39].
PINK1 is constitutively made and continuously degraded by the
mitochondria-speciﬁc proteases presenilin-associated rhomboid-like
protein (PARL) and mitochondrial processing peptidase (MPP). These
proteases are inactivated by the loss of membrane potential across
the inner mitochondrial membrane through an as yet uncharacterized
mechanism; this inactivation results in the accumulation of PINK1 on
the OMM where it can phosphorylate the OMM proteins through its
kinase domain which faces the cytosol and facilitates the targeting of
said proteins to Parkin [40–42]. The targets of PINK1 include Parkin
itself [43,44], mitofusin 2 (Mfn2) [45], and mitochondrial rho 1 (MIRO)
[46], a component of themicrotubule-associatedmotor complex that an-
chors kinesin to mitochondria. More controversially, voltage-dependent
anion channel 1 (VDAC1) has been suggested to be a Parkin target essen-
tial for mitophagy [34], although this ﬁnding is in dispute [47]. Of those
targets, Mfn2, which under basal conditions functions in mitochondrial
fusion events and links endoplasmic reticulum to mitochondria, acts as
a Parkin receptor during mitophagy following phosphorylation by
PINK1, recruiting Parkin to the mitochondria where it ubiquitinates the
OMM targets. Ubiquitination and proteasomal degradation of MIRO,
Mfn2, and Mfn1 prevent the targeted mitochondria from rejoining
the mitochondrial network through fusion [45,46,48–50]. Further, the
presence of ubiquitin on the OMM proteins facilitates recruitment of
autophagy adapter proteins such as neighbor of BRCA1 (NBR1) or
sequestosome-1 (p62/SQSTM1). These adaptor proteins have an ubiq-
uitin binding domain (UBA) and microtubule-associated protein 1
light chain 3 (LC3) interacting region (LIR) which serves as an anchor
for the developing autophagosomal membrane in proximity to the
tagged mitochondrion in a zipper-like process [51,52]. Other possible
actors in Parkin-dependent mitophagy include SMAD-speciﬁc E3 ubiq-
uitin ligase 1 (SMURF1), although its E3 ubiquitin ligase function ap-
pears to be superﬂuous to its ability to facilitate mitophagy [53]. Yet
another player in promoting Parkin-dependent mitophagy is activating
molecule in Beclin 1-regulated autophagy (Ambra1), which dissociates
from mitochondrial Bcl-2 to bind Beclin1 to initiate autophagy [54,55].
Ambra1 interacts with Parkin to promote mitophagy, but is not a sub-
strate of Parkin [56].
Recently, a number of groups have reported a novel mode of Parkin
activation by PINK1, through the phosphorylation of ubiquitin at its
Serine 65 residue (ubiquitinPhospho − Ser65) [57–59]. The E3 ubiquitin li-
gase function of Parkin is autoinhibited under basal conditions, and is
activated by PINK1 via direct phosphorylation of the conserved Ser65
residue in the Ubl domain and the direct phosphorylation of ubiquitin.
The studies point to a two-step activation mechanism of Parkin in
which an initial phosphorylation of residue Ser65 by PINK1 within the
Ubl domain following mitochondrial depolarization results in a confor-
mational change that disrupts the interaction of said domain and the
C-terminus of Parkin. This “open” conformation primes Parkin for opti-
mal binding of ubiquitinPhospho − Ser65 that results in the active E3 form
of the protein which then targetsmitochondrial membrane proteins for
proteasomal degradation.
In addition to the PINK1/Parkin/ubiquitin axis, Parkin-independent
mitophagy can be initiated through atypical members of the Bcl-2 ho-
mology domain 3 (BH3) family members such as BCL2/adenovirus
E1B 19 kDa protein-interacting protein 3 (BNIP3) and BCL2/adenovirus
E1B 19 kDa protein-interacting protein 3-like protein (BNIP3L aka NIX).
These proteins insert into the OMM and facilitate engulfment by the
autophagosome through a LIR domain that can interact with LC3 iso-
forms, including gamma-aminobutyric acid receptor-associated protein
(GABARAP) and GABARAP-like 1 (GABARAPL1) [60,61]. However,
Bnip3 can also work in conjunction with Parkin, by recruiting Drp1
and Parkin to the mitochondria to promote ﬁssion and mitophagy
[62]. In hypoxic conditionsmitophagy has been reported to bemediated
by the OMMprotein FUN14 domain containing 1 (FUNDC1)which con-
tains a LIR [63] (Fig. 1).
Fig. 1.Overviewofmitophagy. Inactivation ofmitochondria-resident proteases in depolarizedmitochondria leads to an accumulation of PINK1 on the outermitochondrial membrane. The
phosphorylation of outermembrane proteins such asMfn1/2 leads to their ubiquitination by Parkin. The ﬁssionmachinery separates the dysfunctional mitochondrion from the network,
and the ubiquitinated proteins serve as binding sites for autophagy adaptor proteins such as p62. These proteins contain LC3 binding sites, leading to encapsulation of the organelle in an
autophagic vesicle, which is delivered to the lysosome for degradation.
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turnover of individual components may proceed at asynchronous rates
through redistribution of components via fusion events, selective degra-
dation of proteins viamitochondrial proteases, and proteasomal elimina-
tion of some OMM proteins. Even in the case of Parkin-dependent
mitophagy, some outermembrane proteins are recycled through transfer
to the ER [64]. Proteomic studies using heavy isotope labeling [65]
revealed that proteins of the IMM turn over with rates that are similar
to mitochondrial turnover based on historic radiolabeling studies [66,
67], suggesting that IMM proteins (primarily OXPHOS constituents)
may be primarily cleared via mitophagy. This also corresponds to studies
which showed that matrix and OMM were readily redistributed across
the mitochondrial network when fusion and ﬁssion were intact; how-
ever, IMM constituents redistributed much more slowly [24].
1.2. Mitochondrial biogenesis
Over the course of evolution, mitochondrial protein expression and
translationwere transposed to theDNAof the host cell, leaving a residual
circular genome of 16 kb, which in mammals encodes only 13 protein
subunits required for aerobic respiration. Furthermore, mitochondrial
genomes replicate in a manner that is radically different from the mam-
malian DNA replicationmechanisms, utilizing the “bootstrap”method in
which processed transcripts (bootlaces) hybridize with the displaced
parental strand as the replication fork advances [68]. This mechanism
minimizes the occurrence and impact of single-strand breaks that threat-
en genome stability, limit the occurrence of replication-dependent
deletions and insertions, and defend against invading elements such as
viruses.Mitochondrial biogenesis, the secondarmofmitochondrial turn-
over, therefore hinges on coordination of nuclear and mitochondrial-
encoded gene expression.
The key transcription factor that directly and indirectly regulates
the expression of mitochondrial nuclear-encoded proteins is the per-
oxisome proliferator-activated receptor gamma coactivator-1alpha
(PGC-1α) [69]. First identiﬁed for the increase in its transcriptionalactivity in the context of thermogenesis and as the binding partner
of peroxisome proliferator-activated receptor γ (PPARγ), PGC-1α is
a member of the nuclear receptor superfamily, proteins responsible
for assembling macrocomplexes into functional transcriptional machin-
ery at speciﬁc DNA sequences [70,71]. As such, PGC-1α is responsible
for the main thrust of mitochondrial biogenesis in the nucleus by con-
trolling the expression of nuclear respiratory factors 1 and 2 (NRF-1
and NRF-2), transcription factors which themselves control the expres-
sion of mitochondrial transcription factor A (Tfam) [72]. Tfam is a mito-
chondrial resident transcription factor responsible for expression of
mitochondrial genes (tRNAs, rRNAs and 13 subunits of respiratory
chain) from the heavy and light mitochondrial DNA (mtDNA) [73].
Several studies have also conﬁrmed the central role of PGC-1α in mito-
chondrial biogenesis, by demonstrating that increased expression of
PGC-1α in response to stimuli such as cold and exercise leads to in-
creased expression of mitochondrial enzymes such as ATP synthetase
(β-subunit), COX (cytochrome c oxidase) subunits (COX II and COX IV)
and δ-aminolevulinate synthase (δ-ALAS) [74,75]. In all, overexpression
of PGC-1α leads to upregulation of 151 genes that encodemitochondrial
proteins involved in many metabolic functions of mitochondria such as
fatty acid β-oxidation (FAO), tricarboxylic acid cycle and oxidative phos-
phorylation, as well as mitochondrial ribosomal machinery and mito-
chondrial membrane transport proteins [76]. In addition, the PGC-1α
isoform PGC-1β is thought to control increasedmitochondrial biogenesis
and basal oxygen consumption, but is not induced by cold or exercise,
suggesting alternate pathways to induction of mitochondrial biogenesis
[77].
Beyonddirecting the transcription of respiratory chainmRNAs, PGC-
1α also interacts with and increases the expression of downstream
transcription factors such as peroxisome proliferator-activated recep-
tors (PPARs), hormone receptors for estrogen and thyroid hormone, as
well as ERRs (estrogen-related receptors) α and γ [78]. ERRs are a set
of nuclear receptors that lack an associated ligand and are closely linked
withmitochondrial biogenesis in general and PGC-1α in particular [79].
In fact, ERRsmay be a key co-activator of PGC-1α activity, as the effect of
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or mimicked by overexpression of ERRα, demonstrating the close rela-
tionship between PGC-1α activation and ERRα [76]. Another family of
nuclear receptors that plays a role together with PGC-1α in mitochon-
drial biogenesis is the PPARs, which in heterodimerization with mem-
bers of retinoid X receptor (RXR) drives the transcription of nuclear
genes encoding mitochondrial FAO enzymes [80].
Cell signaling cascades are the driving force behind the activation of
PGC-1α. Two pathways of transcriptional activation have been well
characterized: through calcineurin A (CnA) and Ca2+/calmodulin-
dependent protein kinase IV (CaMKIV). CnA interactswith and activates
myocyte enhancer factors 2C and 2D (MEF2C andMEF2D), which regu-
late the transcription of PGC-1α directly [81,82]. MEF2C and 2D are up-
regulated by PGC-1α, which results in a feed forward loop that allows
PGC-1α to continue to drive its own upregulation [83]. CaMKIV
activates PGC-1α by phosphorylating the transcription factor cAMP
response element (CRE)-binding protein (CREB); once phosphorylated,
CREB binds to promoter elements on the PGC-1α gene and strongly
drives its expression [81]. The p38 mitogen-activated protein kinase
(p38 MAPK) and AMP-dependent Kinase (AMPK) have also been impli-
cated as regulators of PGC-1α expression. p38MAPK activity is increased
following exercise, leading to the activation of MEF2 and activating tran-
scription factor 2 (ATF2), both of which upregulate the expression of
PGC-1α [84,85].
The activity of PGC-1α is further highly regulated by post-
translational modiﬁcations: direct phosphorylation by signaling kinases
and acetylation/deacetylation. A number of kinases have been implicat-
ed in control of PGC-1α activity: AMPK and Akt during starvation and
p38 MAPK after endurance exercise [86–88]. The activation of AMPK
in response to glucose depletion results in direct phosphorylation of
PGC-1α on threonine-177 and serine-538, crucial for activation of
PGC-1α-dependent transcription from the PGC-1α promoter [86]. In
a similar fashion, p38MAPK increases the activity of PGC-1α by directly
phosphorylating threonine-262, serine-265, and threonine-268,
resulting in stabilization of the protein and the disruption of the interac-
tion between PGC-1α and its inhibitor p160MBP [87,89]. Conversely,
insulin inhibits the activity of PGC-1α through Akt, which can directly
phosphorylate the serine-570 residue on PGC-1α, or indirectly through
phosphorylation of the Clk2 kinase which then in turn phosphorylates
the C-terminal serine- and threonine-rich regions of PGC-1α, decreas-
ing its co-transcriptional activity [90,91].
Other post-translational control of PGC-1α involves glycogen syn-
thase kinase 3β (GSK3β), which has been shown to inhibit PGC-1α ac-
tivity in response to acute oxidative stress by increasing its proteasomal
degradation and inhibiting the activity of Sirt1, an NAD-dependent
deacetylase thought to activate PGC-1α [92]. Thedeacetylation is crucial
for the activation of PGC-1α, as the protein is heavily acetylated by ace-
tyltransferase GCN5, inhibiting its activity and sequestering it in the
nuclear foci rather than the promoter regions of its target genes [93].
Sirt1 activity is dependent upon the coenzyme nicotinamide adenine
dinucleotide (NAD+), and it is highly sensitive to the changes in energy
requirements of the cell; as the ratio of NAD+/NADH changes in response
to fasting, exercise or redox stress, Sirt1 increases the deacetylation PGC-
1α, resulting in an increase in transcription of PGC-1α targets, leading to
mitochondrial biogenesis [94–96]. AMPK, which directly modulates the
activity of PGC-1α by phosphorylation, may also control its activity indi-
rectly by increasing NAD+ levels in the cell by fatty acid oxidation, in-
creasing the activity of Sirt1 [96]. Ubiquitination and methylation have
also been demonstrated to play a role in regulating the activity of PGC-
1α in response to energy demands and oxidative stress, states that
require mitochondrial biogenesis [97].
Beyond transcription of nuclear and mitochondrial encoded mes-
sages, protein synthesis, import, and assembly must occur. The mRNAs
in mitochondria are translated by the mitochondrial ribosomes in the
matrix, while nuclear-encoded mRNAs are translated in polyribosomes
closely associated with the mitochondrial outer membrane, facilitatingco-translational import [98]. Protein import machinery is complex,
and defects in the process, whether inborn or acquired, can lead to a
range of diseases (reviewed in [99]). Assembly of OXPHOS subunits
depends upon coordination of protein import and mitochondrial pro-
tein synthesis. An imbalance triggers the mitochondrial unfolded pro-
tein response which can culminate in mitophagy [100].
Mitochondrial biogenesis is intimately linked tomitophagy. mTOR, a
central regulator of autophagy, is a serine/threonine kinase that directly
controls mitochondrial biogenesis through activation of PGC-1α and its
gene targets. mTOR also upregulates biogenesis through the mTOR
complex 1 (mTORC1), which prevents the binding of the eukaryotic
translation initiation factor 4E (eIF4E)-binding proteins (4E-BP) to
their targets, stimulating the translation of nuclear encoded mitochon-
drial proteins including members of complex V, complex I, and Tfam
[101,102]. In addition to activation of biogenesis andmitophagy, repres-
sors of biogenesis are important players controllingmitochondrial turn-
over. One of themore recently discovered direct repressors of PGC-1α is
the protein Parkin-interacting substrate, PARIS (ZNF746) [103]. PARIS is
a target of Parkin ubiquitin ligase, which controls the levels of Paris via
the ubiquitin proteasome pathway. Accumulated PARIS in the nucleus
leads to direct inactivation of PGC-1α transcription and inhibition of
PGC-1α-dependent genes. Other repressors ofmitochondrial biogenesis
operate in less directmanner. Another repressor, nuclear co-repressor 1
(Ncor1) acts as a transcriptional repressor of PPARγ, PPARδ and ERR as
well as an inhibitor of their activity by dockingwith histonedeacetylases
such as HDAC3 and SIRT1 thereby curbing the expression and activity of
MEF2, PPARδ, and ERR and their downstream transcriptional targets
involving mitochondrial oxidative metabolism [104] (Fig. 2).
1.3. Mitochondrial lipid turnover
Mitochondria possess two lipid bilayer membrane structures, and
the outer mitochondrial membrane (OMM) and inner mitochondrial
membrane (IMM) differ radically in their composition. Much of the
lipid for both membranes derives from the endoplasmic reticulum
(ER). Importantly, phosphatidic acid derived from the ER is transferred
to the inner leaﬂet of the IMM where it is enzymatically converted to
cardiolipin [105]. Cardiolipin is essential to maintain the high degree
of proton impermeability of the IMM, and defects in its biosynthesis
and remodeling lead to severe mitochondrial defects and myocardial
dysfunction [106,107]. Additional lipids are synthesized in the ER and
transported to the mitochondria by direct membrane interactions and
by diverse shuttle systems. Of note, phosphatidylserine, synthesized in
ER, is converted in IMM to phosphatidylethanolamine and exported
back to ER for conversion to phosphatidylcholine [108]. Sphingolipids
are synthesized in the ER but when ceramides are delivered to the
OMM, they serve as important binding sites for LC3-II, thereby mediat-
ing mitophagy [109]. Mitochondrial membranes have also been sug-
gested as a source for autophagosome membrane lipids, particularly
as the mitochondria are the key site for synthesis of phosphatidyletha-
nolamine needed for lipidation of LC3 [110,111]. During mitophagy,
most of the membrane lipids are degraded in the lysosome, liberating
free fatty acids [112]; this process may be disrupted in the presence of
lipid peroxides, leading to accumulation of lipofuscin [113].
1.4. Experimental methods for examining mitochondrial turnover
1.4.1. Pulse–chase labeling
Classic approaches in monitoring mitochondrial turnover involved
the use of radioactive isotope labeling of mitochondrial proteins [67],
phospholipids [114], and heme groups [66]. Studies of cardiac mito-
chondria revealed an average half-life of 17 days under steady state con-
ditions [115]. This has been conﬁrmedmore recently bynon-radioactive
isotope labeling and proteomic analysis [65,116]. Many of the mito-
chondrial inner membrane/matrix components exhibited coordinated
turnover, suggesting autophagic degradation,whereas outermembrane
Fig. 2. Overview of mitochondrial biogenesis. The bulk of biogenesis is controlled by the transcription factor PGC-1α. External stimuli such as cold, exercise or nutritional deprivation
activate signaling cascades which lead to activation of PGC-1α. PGC-1α activates the transcription of other transcription factors such as NRF1, which are responsible for driving the tran-
scription of nuclear-encoded mitochondrial proteins.
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tion (subsarcolemmal vs. interﬁbrillar) also inﬂuenced turnover rates
[116].1.4.2. Proteomics
Until quite recently, much of the work on the rate of mitochondrial
turnover was performed through proteomic approaches. For example,
Major et al., made use of 2-D PAGE analysis to identify changes in
protein abundance in mitochondria isolated from yeast grown on a
nonfermentable carbon source and then incubated in a buffer contain-
ing an ATP-regenerating system [117]. Using this approach, the group
was able to isolate and identify 60 proteins which exhibited a change
by matrix-assisted laser desorption ionization-TOF (MALDI-TOF) mass
spectrometry, covering roughly 11% of yeast mitochondrial proteins
listed in the MitoP2 database. Further use of this technique allowed
for identiﬁcation of changes in mitochondrial protein levels when
yeast cells were subjected to different temperature conditions. The
authorswere able to identify several groups of proteinswith differential
stability under stress conditions, and presented a mechanism by which
mitochondrial turnover in yeast under conditions of stress involves
mitochondrial resident proteases. The drawbacks to using 2-D PAGE are
the limitations presented by the difﬁculty of resolving low-abundance
or hydrophobic proteins, reproducibility and the low-throughput nature
of the method [118].
An alternate, andmore elegant approach to analyzing themitochon-
drial turnover on a proteome-wide level has been developed by Kim
et al. [65]. The approach makes use of the fact that heavy water (2H2O)
intake is a safe, cost efﬁcient and effective way to induce the incorpora-
tion of 2H into biomolecules. Combined with liquid chromatography–
mass spectrometry (LC–MS), this technique allows for straightforward
and accuratemeasurement of protein half-life inmouse organs. By com-
bining the technique with post-collection data analysis, the group was
able to observe kinetics of 458 liver and heart mitochondrial proteins,
allowing for comparison of wholesale mitochondrial dynamics compar-
ison between the two organs. The data revealed that mouse heart mito-
chondrial proteins had a much longer half-life (slower turnover) than
their analogs in the liver (approximately four times higher). Deeper
analysis of the data revealed that in both tissues, proteins responsiblefor protein folding had a much shorter half-life than those involved in
redox reactions. In contrast, proteins responsible for biosynthesis had a
much faster turnover rate in the heart than in the liver, suggesting
tissue-speciﬁc turnover rates for mitochondria in mammals. Further-
more, the variable turnover rate in proteins from isolated mitochondria
gives further support to the previously stated hypothesis, whereby mi-
tochondria segregate dysfunctional proteins for clearance by autophagy
during cycles of ﬁssion and fusion. The study also emphasizes the signif-
icant role that mitochondrial resident proteases must play in order to
clear dysfunctional protein components and maintain homeostasis in
the organelle. The drawback of this approach is the fact that in this
case protein turnover is analyzed on a global level, from a population
of mitochondria; furthermore, posttranslational modiﬁcations of mito-
chondrial proteins, which may be important in segregating newly-
synthesized from older mitochondria, may be missed by this approach.
On a more practical level, this approach requires access to stable iso-
topes and mass spectrometry equipment, and may be cost prohibitive
for many laboratories.1.4.3. Imaging mitophagy with GFP–LC3
Kim and Lemasters used hepatocytes fromGFP–LC3-transgenicmice
for confocal imaging of autophagosomes as they formed around mito-
chondria labeled with TMRM (tetramethylrhodamine methyl ester)
[119]. In response to nutrient deprivation, autophagosomes formed
around polarized mitochondria which retained the dye until the
autophagosome fully enclosed the mitochondrion. This form of mito-
chondrial autophagy appears to be independent ofmitochondrialmem-
brane potential, in contrast to Parkin-dependent mitophagy, which is
initiated by membrane depolarization and stabilization of PINK1 [37].
The use of mitochondrial colocalization with GFP–LC3 for a quantitative
readout ofmitophagy is challenging, becausemitochondrial engulfment
takes less than 10 min, followed by loss of GFP–LC3 ﬂuorescence soon
after acidiﬁcation. Catching such a dynamic process “in the act”makes
quantitation difﬁcult. A related imaging approach was used by Twig
et al. [24] to examine mitophagy under steady state conditions in Ins1
cells. They noted that mitochondrial ﬁssion resulted in asymmetric
daughter mitochondria; the depolarized mitochondrion was less likely
to undergo subsequent fusion events but rather was engulfed by an
2807A. Stotland, R.A. Gottlieb / Biochimica et Biophysica Acta 1853 (2015) 2802–2811autophagosome within 40 min. These contrasting observations of
mitophagy may reﬂect different processes: one dependent on mito-
chondrial depolarization and PINK1 for Parkin and p62-dependent
mitophagy, and another mediated by increased ROS as described by
Scherz-Shouval et al. [120]. Bnip3, an adaptor for LC3 [121], is induced
to dimerize by ROS [122] and may participate in starvation-induced
mitophagy.
1.4.4. mt-Keima
An alternate approach to studying mitochondrial turnover in-
volves utilizing mitochondria-targeted ﬂuorescent proteins. A study by
Katayama et al. utilized a coral ﬂuorescent protein that is resistant to ly-
sosomal proteases, Keima, which exhibits a green ﬂuorescence at neutral
pH and red ﬂuorescence at acidic pH (inside autolysosomes) [123]. TheFig. 3.MitoTimer. (A) C2C12 cells expressing Tet-inducible MitoTimer, exposed to Dox for 1 h,
shown; smaller insets show the expression levels of MitoTimer green andMitoTimer red ﬂuore
with differential rates of import.authors fused the protein with a mitochondrial signal sequence to local-
ize it to the inner membrane of the mitochondria (mt-Keima). By co-
transfecting cells with mt-Keima and EGFP–Parkin, they were able
to quantitatively observe discrete autophagic events following the
induction of mitophagy by incubation with carbonyl cyanide m-
chlorophenyl hydrazone (CCCP) (mitochondrial membrane uncoupling
agent) and oligomycin (ATP synthase inhibitor). Over a time course, the
green ﬂuorescence of mt-Keima shifted from green to red asmitochon-
dria (ormitochondrial innermembrane components)were delivered to
the lysosomes. Although a powerful tool for studying autophagy in
general and mitophagy in particular, mt-Keima does not address
the mitochondrial biogenesis arm of the turnover, nor does it
provide information on the “age” of the particular mitochondria it is
expressed in.and then imaged at 4, 8, 12, 24, 48 and 72 h. Merged images of green and red channels are
scence. (B) Heterogeneous expression ofMitoTimer ﬂuorescence, indicating mitochondria
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In order to study mitochondrial turnover at the level of a single mi-
tochondrion, our laboratory has developed the MitoTimer protein.
Timer is a mutant of DsRed ﬂuorescent protein developed by Terskikh
et al. [124]. The Timer protein transitions from green ﬂuorescence to a
more stable red conformation as it matures over a span of 48 h. Further-
more, the protein is very stable under physiological conditions, insensi-
tive to variations in ionic strength, and changes in pH between 7.0 and
8.0. Timer or Timer-fusion proteins are widely used to monitor cellular
processes including gene expression, intracellular protein recycling, cell
survival, and the kinetics of viral infection [125–128]. We fused the
Timer protein with the N-terminal mitochondrial signal sequence
from the cytochrome c oxidase subunit VIII (COX8) to target the protein
to the inner membrane of the mitochondria. The protein can be moni-
tored as it matures from green to red over 48 h (Fig. 3A), and it is
retained in the mitochondria for a number of days (presumably corre-
sponding to mitochondrial half-life). We cloned MitoTimer into a con-
struct with a tetracycline-inducible promoter in conjunction with the
reverse tetracycline transactivator (rtTA) to allow for synchronized
and time-restricted expression of MitoTimer. A short (2 h) pulse with
tetracycline, followed by removal of any residual tetracycline, is sufﬁ-
cient to achieveMitoTimer expression across themitochondrial popula-
tion of the cell. In order for mitochondrial fusion to occur, mitochondria
mustmaintain a highmembrane potential [24] and expressmitofusin-1
or -2 (Mfn1/2) [129]. A study by Ferree et al. utilizedMitoTimer to show
that it is evenly distributed across the mitochondrial network in wild
type cells under basal conditions; in contrast, mouse embryonic ﬁbro-
blasts (MEFs) derived from Mfn1/2 double knockout mice displayed a
heterogeneous distribution of green vs. red MitoTimer, demonstrating
that fusion events enablemixing of old and newproteinswithin themi-
tochondrial network [129]. Highmembrane potential is required formi-
tochondrial protein import [130]; thus MitoTimer will not be imported
into dysfunctional mitochondria with low membrane potential [131].
Previous work demonstrated that the rate of diffusional exchange of
contents across the mitochondrial network is fastest for outer mem-
brane constituents, intermediate for matrix contents, and slowest for
inner membrane proteins [132]. Consistent with evidence indicating
that turnover of mitochondrial inner membrane and matrix proteins
depends upon mitophagy [133,134], inhibition of autophagy enhanced
the accumulation of red (older) MitoTimer [129], demonstrating the
utility of the construct for the assessment of mitophagy.
Biogenesis could be assessed after a second Dox pulse to induce
another round of expression (readily evident as green MitoTimer) and
which can reveal mitochondrial subpopulations that are more actively
engaged in protein import, a hallmark of mitochondrial biogenesis.
Interestingly, MitoTimer import during biogenesis in C2C12 cells is not
uniform, but is enriched in a perinuclear zone (Fig. 3B). While this
may be simply due to mRNA proximity, it is possible that the subpopu-
lation of mitochondria enriched for green MitoTimer is specialized
for mitochondrial regeneration. A perinuclear distribution of newly-
synthesized MitoTimer was also noted in neuronal cells, while mature
MitoTimer predominated in the distal portion of the neurites [131]. This
ﬁnding is consistentwith previouswork suggesting that autophagosomes
initiate distally in neurons (near the oldest mitochondria) and then
migrate towards the soma, where they fuse with lysosomes [135].
1.4.6. MitoTimer (constitutive expression)
It is also possible to obtain information about mitochondrial turn-
over by expressingMitoTimer in a constitutive, rather than a condition-
al manner, in animal models. By expressing constitutive MitoTimer in
Drosophila heart tube, Laker et al. demonstrated that exercise training
resulted in an increase in the number of green mitochondria, corre-
sponding to increased mitochondrial biogenesis [136]. Furthermore,
the authors demonstrated the utility of MitoTimer for monitoringmito-
chondrial turnover in mice, where MitoTimer delivered by electropora-
tion was constitutively expressed in skeletal muscle. The ratio of red togreenMitoTimer in the skeletal muscle was increased in mice on a high
fat diet compared to normal chow-fed animals, consistent with loss of
lysosomal function needed formitophagy [137]. Suppression of autoph-
agy results in accumulation of mitochondria with lower membrane
potential and increased oxidative damage [138]. Conversely, Laker
et al. observed an increase in the green:red ratio of MitoTimer in mice
subjected to exercise training, even in the presence of a high fat diet
[136]. Exercise upregulates autophagy (enhancing clearance of older
mitochondria) [139] and also stimulates mitochondrial biogenesis
[140], providing two drivers for the green-shifted ratio of MitoTimer
in their model.
2. Conclusions
Derangements ofmitochondrial turnover are recognized in a growing
number of disorders. The ﬁeld is poised for important new discoveries,
with the advent of new technologies including deuterium oxide labeling
with high resolution mass spectrometry analyses in humans [141] and
the ability to image mitophagy and biogenesis in cells and tissues. Medi-
cine,whichhas traditionally focused on organpathophysiology,maywell
have to adjust its focus to include organelle pathology as an aspect of
human disease.
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